1. Home
  2. XOMA vs NAN Comparison

XOMA vs NAN Comparison

Compare XOMA & NAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • NAN
  • Stock Information
  • Founded
  • XOMA 1981
  • NAN 1999
  • Country
  • XOMA United States
  • NAN United States
  • Employees
  • XOMA N/A
  • NAN N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • NAN Investment Managers
  • Sector
  • XOMA Health Care
  • NAN Finance
  • Exchange
  • XOMA Nasdaq
  • NAN Nasdaq
  • Market Cap
  • XOMA 330.2M
  • NAN 342.0M
  • IPO Year
  • XOMA N/A
  • NAN N/A
  • Fundamental
  • Price
  • XOMA $32.47
  • NAN $10.97
  • Analyst Decision
  • XOMA Strong Buy
  • NAN
  • Analyst Count
  • XOMA 2
  • NAN 0
  • Target Price
  • XOMA $69.50
  • NAN N/A
  • AVG Volume (30 Days)
  • XOMA 57.0K
  • NAN 74.6K
  • Earning Date
  • XOMA 08-13-2025
  • NAN 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • NAN 4.37%
  • EPS Growth
  • XOMA N/A
  • NAN N/A
  • EPS
  • XOMA N/A
  • NAN N/A
  • Revenue
  • XOMA $44,952,000.00
  • NAN N/A
  • Revenue This Year
  • XOMA $82.30
  • NAN N/A
  • Revenue Next Year
  • XOMA $12.59
  • NAN N/A
  • P/E Ratio
  • XOMA N/A
  • NAN N/A
  • Revenue Growth
  • XOMA 194.98
  • NAN N/A
  • 52 Week Low
  • XOMA $18.35
  • NAN $9.11
  • 52 Week High
  • XOMA $35.23
  • NAN $11.34
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 61.79
  • NAN 37.01
  • Support Level
  • XOMA $32.60
  • NAN $10.89
  • Resistance Level
  • XOMA $34.60
  • NAN $10.94
  • Average True Range (ATR)
  • XOMA 1.82
  • NAN 0.06
  • MACD
  • XOMA 0.09
  • NAN -0.00
  • Stochastic Oscillator
  • XOMA 66.75
  • NAN 33.33

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About NAN Nuveen New York Quality Municipal Income Fund

Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: